X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (1251) 1251
humans (1211) 1211
proliferating cell nuclear antigen - biosynthesis (902) 902
male (863) 863
proliferating cell nuclear antigen (738) 738
female (737) 737
proliferating cell nuclear antigen - metabolism (713) 713
index medicus (700) 700
immunohistochemistry (629) 629
rats (516) 516
mice (447) 447
oncology (397) 397
apoptosis (380) 380
cell proliferation (367) 367
expression (356) 356
cell biology (343) 343
cell cycle (336) 336
proliferating cell nuclear antigen - analysis (329) 329
proliferating cell nuclear antigen - genetics (325) 325
middle aged (323) 323
adult (299) 299
proteins (299) 299
biochemistry & molecular biology (297) 297
pcna (293) 293
cell division (284) 284
cancer (281) 281
dna - biosynthesis (270) 270
aged (254) 254
dna replication (254) 254
gene expression (247) 247
proliferation (236) 236
dna (230) 230
cells, cultured (229) 229
cell nuclear antigen (207) 207
dna biosynthesis (202) 202
rats, sprague-dawley (195) 195
research article (188) 188
dna damage (182) 182
tumor suppressor protein p53 - biosynthesis (181) 181
protein (180) 180
deoxyribonucleic acid--dna (174) 174
replication (174) 174
cell proliferation - drug effects (169) 169
pathology (168) 168
cell division - drug effects (166) 166
analysis (165) 165
dna repair (159) 159
cells (154) 154
prognosis (153) 153
research (147) 147
multidisciplinary sciences (146) 146
p53 (146) 146
time factors (146) 146
cell line, tumor (141) 141
medicine (140) 140
mutation (139) 139
rats, wistar (137) 137
apoptosis - drug effects (136) 136
blotting, western (135) 135
molecular sequence data (133) 133
cell line (132) 132
gene-expression (129) 129
antigens (128) 128
phosphorylation (125) 125
rna, messenger - biosynthesis (123) 123
growth (121) 121
science (115) 115
tumors (115) 115
differentiation (111) 111
biology (110) 110
gene (109) 109
aged, 80 and over (106) 106
base sequence (103) 103
cell growth (102) 102
article (101) 101
tumor cells, cultured (101) 101
dose-response relationship, drug (100) 100
rna, messenger - genetics (100) 100
kinases (99) 99
disease models, animal (98) 98
in-vitro (98) 98
signal transduction (98) 98
inhibition (96) 96
gene expression regulation, neoplastic (95) 95
toxicology (95) 95
activation (94) 94
dna-binding proteins - metabolism (92) 92
biochemistry (91) 91
carcinoma (91) 91
in situ nick-end labeling (91) 91
protein binding (91) 91
reverse transcriptase polymerase chain reaction (90) 90
enzymes (89) 89
nuclear antigen (88) 88
deoxyribonucleic acid (87) 87
genes (87) 87
flow cytometry (86) 86
nuclear proteins - biosynthesis (86) 86
rna, messenger - metabolism (85) 85
dna-directed dna polymerase - metabolism (84) 84
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2261) 2261
Chinese (149) 149
Russian (13) 13
Japanese (7) 7
Italian (3) 3
Spanish (2) 2
German (1) 1
Polish (1) 1
Portuguese (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Oncogene, ISSN 0950-9232, 08/2011, Volume 30, Issue 31, pp. 3454 - 3467
It is necessary to understand mechanisms by which differentiating agents influence tumor-initiating cancer stem cells. Toward this end, we investigated the... 
retinoic acid | differentiation | glioblastoma | cancer stem cell | Notch | APOPTOSIS | DIFFERENTIATION THERAPY | GLIOMA | BIOCHEMISTRY & MOLECULAR BIOLOGY | HEPATOCYTE GROWTH-FACTOR | 13-CIS-RETINOIC ACID | PHASE-II | U87MG CELLS | EMBRYONAL CARCINOMA | CANCER | CELL BIOLOGY | ONCOLOGY | GENETICS & HEREDITY | NEURAL DIFFERENTIATION | Nestin | Peptides | Antigens, CD - biosynthesis | Neoplastic Stem Cells - drug effects | Humans | Brain Neoplasms - pathology | Antineoplastic Agents - therapeutic use | Gene Expression Profiling | RNA-Binding Proteins - biosynthesis | Receptors, Notch - antagonists & inhibitors | Glioblastoma - genetics | Neoplastic Stem Cells - metabolism | Proliferating Cell Nuclear Antigen - biosynthesis | Nerve Tissue Proteins - biosynthesis | Female | Antineoplastic Agents - pharmacology | Gene Expression Regulation, Neoplastic - drug effects | Tretinoin - pharmacology | Tubulin - biosynthesis | Brain Neoplasms - genetics | Intermediate Filament Proteins - biosynthesis | Cyclin D1 - biosynthesis | SOXB1 Transcription Factors - biosynthesis | AC133 Antigen | Glial Fibrillary Acidic Protein - biosynthesis | Glycoproteins - biosynthesis | Animals | Tretinoin - therapeutic use | Cell Differentiation - drug effects | Mice, Nude | Glioblastoma - pathology | Cell Line, Tumor | Mice | Care and treatment | Stem cells | Diagnosis | Research | Glioblastoma multiforme | Health aspects | Tretinoin | Oncology | Cellular biology | Gene expression | Brain cancer | Tumors
Journal Article
Journal Article
PLoS Genetics, ISSN 1553-7390, 2014, Volume 10, Issue 6, p. e1004419
Journal Article
Medical Oncology, ISSN 1357-0560, 1/2015, Volume 32, Issue 1, pp. 1 - 9
Journal Article
Aquatic Toxicology, ISSN 0166-445X, 2006, Volume 80, Issue 3, pp. 217 - 227
We investigated whether exposure to environmentally relevant concentrations of the bactericidal agent, triclosan, induces changes in the thyroid... 
XTC-2 | Environmental contaminant | Irgasan | Thyroid hormone | Endocrine disruptor | Triclosan | Metamorphosis | Rana catesbeiana | environmental contaminant | thyroid hormone | WASTE-WATER CONTAMINANTS | DETROIT RIVER | triclosan | irgasan | MASS-SPECTROMETRY | GAS-CHROMATOGRAPHY | TREATMENT PLANTS | MARINE & FRESHWATER BIOLOGY | endocrine disruptor | XENOPUS-LAEVIS TADPOLES | TOXICOLOGY | metamorphosis | PERSONAL-CARE PRODUCTS | SURFACE WATERS | RANA-CATESBEIANA TADPOLES | Receptors, Thyroid Hormone - drug effects | Triiodothyronine - physiology | Gene Expression - drug effects | Reverse Transcriptase Polymerase Chain Reaction - veterinary | Body Weight - drug effects | Triclosan - toxicity | DNA Primers - chemistry | RNA, Messenger - metabolism | Brain - metabolism | Proliferating Cell Nuclear Antigen - genetics | Receptors, Thyroid Hormone - genetics | Proliferating Cell Nuclear Antigen - biosynthesis | Time Factors | Anti-Bacterial Agents - chemistry | Anti-Bacterial Agents - toxicity | Metamorphosis, Biological - drug effects | RNA, Messenger - drug effects | Rana catesbeiana - physiology | Cell Line | Receptors, Thyroid Hormone - biosynthesis | Xenopus laevis | Gene Expression Regulation, Developmental - drug effects | Rana catesbeiana - growth & development | Triiodothyronine - chemistry | Proliferating Cell Nuclear Antigen - drug effects | Triclosan - chemistry | Brain - drug effects | Rana catesbeiana - genetics | Animals | Water Pollutants, Chemical - toxicity | Triiodothyronine | Messenger RNA | Gene expression | Amphibians | Protein binding
Journal Article
Journal Article
Pediatric Blood & Cancer, ISSN 1545-5009, 08/2015, Volume 62, Issue 8, pp. 1414 - 1420
Background Infantile hemangioma (IH) is a benign vascular neoplasm resulting from the abnormal proliferation of endothelial cells and pericytes in infants.... 
eNOS | infantile hemangioma | VEGF | propranolol | Infantile hemangioma | Propranolol | ENOS | ANGIOGENESIS | NITRIC-OXIDE SYNTHASE | PANCREATIC-CANCER | ACTIN DYNAMICS | PROGENITOR-CELL | ONCOLOGY | SIGNALING PATHWAY | IN-VIVO | INFANTILE HEMANGIOMAS | PEDIATRICS | HEMATOLOGY | EXPRESSION | ENDOTHELIAL GROWTH-FACTOR | Norepinephrine - pharmacology | Vascular Endothelial Growth Factor A - biosynthesis | Phosphorylation | Humans | Nitric Oxide Synthase Type III - biosynthesis | Propranolol - therapeutic use | Infant | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Phosphatidylinositol 3-Kinases - antagonists & inhibitors | Vascular Endothelial Growth Factor Receptor-2 - antagonists & inhibitors | Proliferating Cell Nuclear Antigen - biosynthesis | Neoplasm Invasiveness - pathology | Angiogenesis Inhibitors - therapeutic use | Nitric Oxide Synthase Type III - metabolism | Chromones - pharmacology | Hemangioma - drug therapy | Phosphatidylinositol 3-Kinases - biosynthesis | Proto-Oncogene Proteins c-akt - metabolism | Infant, Newborn | Adrenergic beta-Antagonists - therapeutic use | NG-Nitroarginine Methyl Ester - pharmacology | Nitric Oxide - biosynthesis | Cyclin A2 - biosynthesis | Cyclin-Dependent Kinase Inhibitor p21 - biosynthesis | Endothelial Cells - metabolism | Pericytes - metabolism | Cells, Cultured | Morpholines - pharmacology | Vascular Endothelial Growth Factor Receptor-2 - metabolism | Cinnamates - pharmacology | Nitric Oxide Synthase Type III - antagonists & inhibitors | Proto-Oncogene Proteins c-akt - biosynthesis | Vascular Endothelial Growth Factor Receptor-1 - pharmacology | Cell Cycle Checkpoints - drug effects | Neovascularization, Pathologic - drug therapy | Cell Proliferation - drug effects | Cyclin D2 - biosynthesis | Proteins | Propranolol hydrochloride | Hemangioma | Vascular endothelial growth factor | Cell proliferation | Regression | AKT protein | Infants | Endothelial cells | 1-Phosphatidylinositol 3-kinase | Cyclin D2 | Vascular endothelial growth factor receptors | Antiangiogenics | Cell cycle | Cofilin | Pericytes | Norepinephrine | Inhibition | Pretreatment | Cancer
Journal Article
Journal Article
Biological Trace Element Research, ISSN 0163-4984, 12/2018, Volume 186, Issue 2, pp. 489 - 497
Journal Article